Literature DB >> 18360897

Prevalence and risk factors for viral hepatitis in the Kosovarian population: implications for health policy.

Gianluca Quaglio1, Naser Ramadani, Cristian Pattaro, Arben Cami, Pietro Dentico, Anna Volpe, Giampiero Pellizzer, Ali Berisha, Camillo Smacchia, Mario Figliomeni, Nicola Schinaia, Giovanni Rezza, Giovanni Putoto.   

Abstract

The prevalence of hepatitis infection among the Kosovarian population is largely unknown. The aim of the study was to evaluate the prevalence and risk factors of hepatitis A, B, C, and D (HAV, HBV, HCV, HDV) infection among the general population and in a group of health care workers in the Kosovo region. Overall, 1,287 participants were recruited, 460 males (36%) and 827 females (64%). Health care workers accounted for 253 individuals (20%), 301 were blood donor candidates (23%), 334 were pregnant women (26%), and 399 (31%) were subjects who had been examined in two clinics for routine laboratory testing. The prevalence of total anti-HAV was 88.6% (95% CI: 86.69-90.25). Prevalence of anti-HAV among children up to 10 years was 40.5% (95% CI: 29.6-53.15), reaching 70% (95% CI: 62.25-77.10) in the 11-20 age group. Age, living in rural areas and unemployment were factors associated with higher risk of HAV infection. HBsAg was detected in 2.4% (95% CI: 1.57-3.38%) of the study sample, with a significant age trend (P-value:0.0110). Positivity for total anti-HBc was detected in 18.4% (95% CI = 16.27-20.59) of the subjects. Ninety-three subjects (7.2%) were positive for anti-HBs alone. An association between age, HSV-2 positivity, working nurses and HBV infection has been observed. One patient was HDV positive. The prevalence for HCV was 0.5% (95% CI: 0.22-1.12%). HAV infection seems to be high-intermediate, while HBV shows an intermediate endemicity. It is necessary to highlight the importance of an immunization strategy against HAV and HBV in reducing the incidence of the infection. The prevalence for HCV was very low.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18360897     DOI: 10.1002/jmv.21141

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

Review 1.  Hepatitis D Virus: Introduction and Epidemiology.

Authors:  Mario Rizzetto
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-01       Impact factor: 6.915

Review 2.  Epidemiology of hepatitis C in Croatia in the European context.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Bernard Kaic; Maja Vilibic; Nenad Pandak; Ljubo Barbic; Vladimir Stevanovic; Jasmina Vranes
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

3.  Seroepidemiology of hepatitis a in the croatian population.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Suncanica Ljubin-Sternak; Branko Kolaric
Journal:  Hepat Mon       Date:  2011-12-20       Impact factor: 0.660

4.  A very high prevalence of hepatitis C virus infection among patients undergoing hemodialysis in Kosovo: a nationwide study.

Authors:  Xhevat Jakupi; Jana Mlakar; Maja M Lunar; Katja Seme; Ibrahim Rudhani; Lul Raka; Adriana Vince; Mario Poljak
Journal:  BMC Nephrol       Date:  2018-11-03       Impact factor: 2.388

5.  Declining seroprevalence of hepatitis A in Vojvodina, Serbia.

Authors:  Snežana Medić; Cleo Anastassopoulou; Vesna Milošević; Nataša Dragnić; Smiljana Rajčević; Mioljub Ristić; Vladimir Petrović
Journal:  PLoS One       Date:  2019-06-04       Impact factor: 3.240

6.  Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world.

Authors:  Jaspreet Toor; Susy Echeverria-Londono; Xiang Li; Kaja Abbas; Emily D Carter; Hannah E Clapham; Andrew Clark; Margaret J de Villiers; Kirsten Eilertson; Matthew Ferrari; Ivane Gamkrelidze; Timothy B Hallett; Wes R Hinsley; Daniel Hogan; John H Huber; Michael L Jackson; Kevin Jean; Mark Jit; Andromachi Karachaliou; Petra Klepac; Alicia Kraay; Justin Lessler; Xi Li; Benjamin A Lopman; Tewodaj Mengistu; C Jessica E Metcalf; Sean M Moore; Shevanthi Nayagam; Timos Papadopoulos; T Alex Perkins; Allison Portnoy; Homie Razavi; Devin Razavi-Shearer; Stephen Resch; Colin Sanderson; Steven Sweet; Yvonne Tam; Hira Tanvir; Quan Tran Minh; Caroline L Trotter; Shaun A Truelove; Emilia Vynnycky; Neff Walker; Amy Winter; Kim Woodruff; Neil M Ferguson; Katy Am Gaythorpe
Journal:  Elife       Date:  2021-07-13       Impact factor: 8.140

7.  Implications of a change in case definition and screening of asylum seekers for hepatitis B surveillance in Germany in 2015 and 2016.

Authors:  A von Laer; M Diercke; M An der Heiden; D Altmann; R Zimmermann; S Dudareva
Journal:  Epidemiol Infect       Date:  2020-02-24       Impact factor: 2.451

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.